On that same topic:
“Cannabinoid Hyperemesis Syndrome”
Lauren Cue; Frederick Chu; Marco Cascella.
July 3, 2023.
https://www.ncbi.nlm.nih.gov/books/NBK549915/
“Probably, a crucial factor in the genesis of CHS is the composition of cannabis. Since the 1990s, there has been a progressive change in the composition of the plant, with increases in the tetrahydrocannabinol (THC) and a reduction of cannabidiol (CBD). This trend correlates with increased cannabis use. Some individuals, for instance, also admitted to smoking 2000 mg of THC per day.”
“CHS is a relatively new disorder that is not only difficult to diagnose but to manage. To lower the morbidity, CHS is best managed by an interprofessional team.
“As CHS is a relatively recently recognized and studied phenomenon easily confused with other diseases, there is a paucity of sizeable randomized control studies. Most resources and recommendations come from case studies and expert opinions. In addition to appropriate antiemetic therapy, fluid resuscitation, and management of the patient’s symptoms, patients must recognize behaviors and exposures that place them at risk for their pathology. For supportive care, a clinician should work together with the pharmacist to see if any medications could contribute to the patient’s presentation. If administering antiemetics, the nursing staff should be familiar with the adverse event profile so they can report any concerns that may arise.”
There was actually a thread on that yesterday
I’ve never seen it
Not once
And my observation pool is fairly large
Showers work much better than anti empties.